Neural Regeneration Research,
Journal Year:
2024,
Volume and Issue:
20(1), P. 159 - 173
Published: April 3, 2024
Brain-derived
neurotrophic
factor
is
a
key
in
stress
adaptation
and
avoidance
of
social
behavioral
response.
Recent
studies
have
shown
that
brain-derived
expression
stressed
mice
brain
region–specific,
particularly
involving
the
corticolimbic
system,
including
ventral
tegmental
area,
nucleus
accumbens,
prefrontal
cortex,
amygdala,
hippocampus.
Determining
how
participates
processing
different
regions
will
deepen
our
understanding
psychopathology.
In
this
review,
we
discuss
regulation
stress-sensitive
closely
related
to
pathophysiology
depression.
We
focused
on
associated
molecular
pathways
neural
circuits,
with
special
attention
factor–tropomyosin
receptor
kinase
B
signaling
pathway
area–nucleus
accumbens
dopamine
circuit.
determined
stress-induced
alterations
levels
are
likely
nature,
severity,
duration
stress,
especially
above-mentioned
system.
Therefore,
BDNF
might
be
biological
indicator
regulating
stress-related
processes
various
regions.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(19), P. 11076 - 11076
Published: Sept. 21, 2022
Depression
and
anxiety
disorders
are
the
two
most
prevalent
psychiatric
diseases
that
affect
hundreds
of
millions
individuals
worldwide.
Understanding
etiology
related
mechanisms
is
great
importance
might
yield
new
therapeutic
strategies
to
treat
these
effectively.
During
past
decades,
a
growing
number
studies
have
pointed
out
stress-induced
inflammatory
response
in
amygdala,
kernel
region
for
processing
emotional
stimuli,
as
potentially
critical
contributor
pathophysiology
depression
disorders.
In
this
review,
we
first
summarized
recent
progress
from
both
animal
human
toward
understanding
causal
link
between
inflammation
disorders,
with
particular
emphasis
on
findings
showing
effect
functional
changes
neurons
at
levels
ranging
molecular
signaling,
cellular
function,
synaptic
plasticity,
neural
circuit
behavior,
well
their
contributions
pathology
inflammation-related
Finally,
concluded
by
discussing
some
difficulties
surrounding
current
research
propose
issues
worth
future
study
field.
Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: Jan. 2, 2025
Abstract
Radiopharmaceuticals
involve
the
local
delivery
of
radionuclides
to
targeted
lesions
for
diagnosis
and
treatment
multiple
diseases.
Radiopharmaceutical
therapy,
which
directly
causes
systematic
irreparable
damage
cells,
has
attracted
increasing
attention
in
refractory
diseases
that
are
not
sensitive
current
therapies.
As
Food
Drug
Administration
(FDA)
approvals
[
177
Lu]Lu-DOTA-TATE,
Lu]Lu-PSMA-617
their
complementary
diagnostic
agents,
namely,
68
Ga]Ga-DOTA-TATE
Ga]Ga-PSMA-11,
radiopharmaceutical-based
theranostics
(radiotheranostics)
being
increasingly
implemented
clinical
practice
oncology,
lead
a
new
era
radiopharmaceuticals.
The
generation
radiopharmaceuticals
utilizes
targeting
vector
achieve
accurate
avoid
off-target
deposition,
making
it
possible
improve
efficiency
biosafety
tumour
therapy.
Numerous
studies
have
focused
on
developing
novel
broader
range
disease
targets,
demonstrating
remarkable
vivo
performance.
These
include
high
tumor
uptake,
prolonged
retention
time,
favorable
pharmacokinetic
properties
align
with
standards.
While
radiotheranostics
been
widely
applied
applications
now
expanding
neurodegenerative
diseases,
cardiovascular
inflammation.
Furthermore,
radiotheranostic-empowered
precision
medicine
is
revolutionizing
cancer
paradigm.
Diagnostic
play
pivotal
role
patient
stratification
planning,
leading
improved
therapeutic
outcomes
radionuclide
This
review
offers
comprehensive
overview
evolution
radiopharmaceuticals,
including
both
FDA-approved
clinically
investigated
explores
mechanisms
cell
death
induced
by
It
emphasizes
significance
future
prospects
theranostic-based
advancing
medicine.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: April 17, 2023
Abstract
Nucleus-
and
cell-specific
interrogation
of
individual
basal
forebrain
(BF)
cholinergic
circuits
is
crucial
for
refining
targets
to
treat
comorbid
chronic
pain-like
depression-like
behaviour.
As
the
ventral
pallidum
(VP)
in
BF
regulates
pain
perception
emotions,
we
aim
address
role
VP-derived
hyperalgesia
behaviour
mouse
model.
In
male
mice,
VP
neurons
innervate
local
non-cholinergic
modulate
downstream
basolateral
amygdala
(BLA)
through
nicotinic
acetylcholine
receptors.
These
are
mobilized
by
stimuli
become
hyperactive
during
persistent
pain.
Acute
stimulation
VP-BLA
projection
reduces
threshold
naïve
mice
whereas
inhibition
elevated
states.
Multi-day
repetitive
modulation
pathway
Therefore,
implicated
Biological Psychiatry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Physical
social
defeat
stress
models
are
widely
used
to
study
chronic
stress.
In
contrast,
witnessing
defeat,
observing
aggression
without
direct
involvement,
is
less
studied
but
has
growing
relevance
disorders
such
as
post-traumatic
disorder
(PTSD).
The
role
of
hyperpolarization-activated
cation
channel
1
(HCN1)
in
responses
unclear,
and
the
effects
prolonged
exposure
(PE)
therapy,
commonly
PTSD
treatment,
have
not
been
tested
this
context.
Male
mice
were
either
subjected
physical
or
Behavioral
assessments
included
measures
avoidance,
reactivity,
fear
memory,
spatial
working
memory.
Neuronal
excitability,
h
current
(Ih),
synaptic
transmission
dorsal
hippocampal
CA1
neurons
measured
using
whole-cell
patch-clamp
recordings.
Conditional
overexpression
deletion
HCN1
was
employed
further
examine
its
role.
Witnessing-defeated
underwent
12
days
PE
treatment.
Mice
that
witnessed
exhibited
behavioral
impairments
like
physically
defeated
mice,
showing
changes
behavior,
responses.
These
linked
increased
expression,
elevated
Ih,
reduced
neuronal
excitability.
Overexpression
induced
susceptibility-like
behaviors,
while
promoted
resilience-like
behaviors.
Impaired
AMPA
receptor
at
distal
dendrites
witness-susceptible
replicated
by
reversed
ZD7288,
an
HCN
blocker.
PE-resistant
displayed
PE-responsive
normal-like
channels
play
a
key
regulating
contribute
resilience
susceptibility
following
defeat.
Biomedicines,
Journal Year:
2022,
Volume and Issue:
10(5), P. 1005 - 1005
Published: April 27, 2022
Major
depressive
disorder
(MDD)
is
a
common
neuropsychiatric
affecting
the
mood
and
mental
well-being.
Its
pathophysiology
remains
elusive
due
to
complexity
heterogeneity
of
this
that
affects
millions
individuals
worldwide.
Chronic
stress
frequently
cited
as
one
risk
factors
for
MDD.
To
date,
conventional
monoaminergic
theory
(serotonin,
norepinephrine,
and/or
dopamine
dysregulation)
has
received
most
attention
in
treatment
MDD,
all
available
classes
antidepressants
target
these
systems.
However,
contributions
other
neurotransmitter
systems
MDD
have
been
widely
reported.
Emerging
preclinical
clinical
findings
reveal
maladaptive
glutamatergic
neurotransmission
might
underlie
thus
revealing
its
critical
role
neurobiology
therapeutic
target.
Aiming
beyond
hypothesis,
studies
neurobiological
mechanisms
underlying
stress-induced
impairment
AMPA
(a-amino-3-hydroxy-5-methyl-4-isoxazole
propionic
acid)-glutamatergic
brain
could
provide
novel
insights
development
new
generation
without
detrimental
side
effects.
Here,
authors
reviewed
recent
literature
focusing
on
AMPA-glutamatergic
responses
emotional
mood-associated
regions,
including
hippocampus,
amygdala,
prefrontal
cortex,
nucleus
accumbens
periaqueductal
gray.
Major
depressive
disorder
is
a
severe
psychiatric
that
afflicts
~17%
of
the
world
population.
Neuroimaging
investigations
depressed
patients
have
consistently
reported
dysfunction
basolateral
amygdala
in
pathophysiology
depression.
However,
how
BLA
and
related
circuits
are
implicated
pathogenesis
depression
poorly
understood.